prof. Jan De Waele
- Work address
-
C. Heymanslaan 10, ingang 12 - verdieping 6
9000 Gent - Jan.DeWaele@UGent.be
- ORCID iD
-
0000-0003-1017-9748
- Bio (via ORCID)
- Jan De Waele is a surgery-trained intensivist with a specific interest in infections in critically ill patients and works at the surgical ICU of the Ghent University Hospital in Belgium. Clinical interests include infections and abdominal catastrophes such as the abdominal compartment syndrome. His research activities currently focus on optimizing antibiotic therapy in severely ill infected patients to improve outcome and combat resistance development. He is active in several societies: he is currently chairing the Infection Section of the ESICM and president of the Belgian Society of Intensive Care Medicine.
Show
Sort by
-
- Journal Article
- open access
Variation in communication and family visiting policies in intensive care within and between countries during the Covid-19 pandemic: The COVISIT international survey
-
- Journal Article
- open access
Epidemiology and Age-Related Mortality in Critically Ill Patients With Intra-Abdominal Infection or Sepsis: An International Cohort Study
-
Artificial intelligence in infection management in the ICU
-
Effects of cascade reporting of susceptibility profiles for Enterobacterales on broad-spectrum antibiotics use and resistance
-
European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society of intensive care medicine)
-
Comment on : Penetration of antibacterial agents into pulmonary epithelial lining fluid : an update
-
An international survey of adherence to Surviving Sepsis Campaign Guidelines 2016 regarding fluid resuscitation and vasopressors in the initial management of septic shock
-
Infection control in the intensive care unit : expert consensus statements for SARS-CoV-2 using a Delphi method
-
Antibiotic dosing in sustained low-efficiency daily dialysis (SLEDD) : basic concepts and dosing strategies
-
Prediction of cardiac surgery associated-acute kidney injury (CSA-AKI) by healthcare professionals and urine cell cycle arrest AKI biomarkers [TIMP-2]*[IGFBP7] : a single center prospective study (the PREDICTAKI trial)